Literature DB >> 28803998

High serum lactate as an adjunct in the early prediction of anastomotic leak following oesophagectomy.

B Ip1, K T Ng2, S Packer3, S Paterson-Brown2, G W Couper2.   

Abstract

BACKGROUND: Anastomotic leak (AL) following oesophagectomy carries a high mortality and morbidity. Early detection and intervention is required for a successful outcome. We have examined the role of a high postoperative serum lactate in predicting which patients are at risk of developing an anastomotic leak(AL).
MATERIALS AND METHODS: All patients who underwent transthoracic oesophagectomy over a 3-year period were identified from a prospectively collected database. Medical records were reviewed to identify the highest serum lactate recorded from blood gas analysis over each 24hr post-operative period. Patients who underwent transhiatal and left thoraco-abdominal oesophagectomies were excluded. Patients who developed a chyle leak were excluded.
RESULTS: Of a total of 136 oesophagectomies included for analysis, 18 developed an AL (13.2%). Of these patients, 10 underwent thoracoscopic oesophageal mobilization with cervical anastomosis and the rest an Ivor Lewis procedure. Predictive factors for AL included neoadjuvant chemotherapy (15/18 83.3% vs 55/118 46.6% p = 0.0046) and number of positive lymph nodes (mean 4.2 vs control mean 2.3 p = 0.045). Overall net fluid balance was comparable between the 2 groups, although AL patients received slightly more fluid on Day 3. High lactate levels on days 1-3 were associated with an AL. Using a Day 2 lactate of 1.7 mmol/L, the sensitivity of predicting AL was 72% and specificity 88%. The mean lag time using existing diagnostic modalities was 7.9 days.
CONCLUSION: A serum lactate of >1.7 mmol/l on day 2 should raise the possibility of a potential AL. Such patients should be selected for more intensive monitoring, optimization and selective gastroscopy. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anastomotic leak; Lactate; Oesophagectomy

Mesh:

Substances:

Year:  2017        PMID: 28803998     DOI: 10.1016/j.ijsu.2017.08.027

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Serum albumin at resection predicts in-hospital death, while serum lactate and aPTT on the first postoperative day anticipate anastomotic leakage after Ivor-Lewis-esophagectomy.

Authors:  Florian Scheufele; Thomas Vogel; Melanie Gasiorek; Alexander Novotny; Helmut Friess; Ihsan Ekin Demir; Stephan Schorn
Journal:  Langenbecks Arch Surg       Date:  2022-04-28       Impact factor: 2.895

2.  Impact of postoperative complications on survival after oesophagectomy for oesophageal cancer.

Authors:  J R Bundred; A C Hollis; R Evans; J Hodson; J L Whiting; E A Griffiths
Journal:  BJS Open       Date:  2020-02-17

3.  Risk Factors of Cervical Anastomotic Leakage after McKeown Minimally Invasive Esophagectomy: Focus on Preoperative and Intraoperative Lung Function.

Authors:  Wenda Gao; Mingbo Wang; Peng Su; Fan Zhang; Chao Huang; Ziqiang Tian
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-10-20       Impact factor: 1.520

4.  Usefulness of delta neutrophil index as a biomarker to predict postoperative complication in patients who underwent esophagectomy: A case-control study.

Authors:  Seong Chan Gong; Hoon Ryu; Ji Young Jang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

5.  A nomogram illustrating the probability of anastomotic leakage following cervical esophagogastrostomy.

Authors:  Joerg Lindenmann; Nicole Fink-Neuboeck; Christian Porubsky; Melanie Fediuk; Udo Anegg; Peter Kornprat; Maria Smolle; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  Surg Endosc       Date:  2020-10-26       Impact factor: 4.584

6.  Oxidative Stress Level as a Predictor of Anastomotic Leakage after Rectal Surgery.

Authors:  Jiajun Luo; Hongxue Wu; Yu Yang; Yue Jiang; Jingwen Yuan; Qiang Tong
Journal:  Mediators Inflamm       Date:  2021-06-28       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.